Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
KVUE
)
18.22
-0.03 (-0.16%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about KVUE
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
2 Exceptional Dividend Stocks Near 52-Week Lows. Are They Bargains Now?
October 25, 2023
Attractive valuation metrics don't always tell the whole story.
Via
The Motley Fool
The Best Stocks to Invest $5,000 In Right Now
October 24, 2023
Today, the following three healthcare players look like fantastic bargains.
Via
The Motley Fool
Peering Into Kenvue's Recent Short Interest
October 23, 2023
Via
Benzinga
Down in the Double Digits, These 2 Classic Warren Buffett Stocks Make Great Buys Now
October 22, 2023
These players could deliver top returns over the long haul.
Via
The Motley Fool
3 Foundational Blue Chip Dow Dividend Stocks for Building Generational Wealth
October 22, 2023
Dow stocks can provide the confidence needed to hold through periods of volatility.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
These 2 Dow Stocks Moved Markets This Week
October 21, 2023
Bulls and bears alike looked closely at these two companies.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Check Out What Whales Are Doing With KVUE
October 12, 2023
Via
Benzinga
Price Over Earnings Overview: Kenvue
October 11, 2023
Via
Benzinga
(KVUE) - Analyzing Kenvue's Short Interest
October 05, 2023
Via
Benzinga
7 Healthcare Stocks That Can Cure a Lackluster Portfolio
October 19, 2023
Take a position in these companies' stocks to achieve long-term gains and give a jolt to your investment portfolio.
Via
InvestorPlace
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
October 19, 2023
Investors wonder if the healthcare giant can keep raising its payout now that it no longer sells the consumer health brands that made it famous.
Via
The Motley Fool
Why Johnson & Johnson Stock Flopped Today
October 18, 2023
Perhaps those third-quarter results weren't as impressive as they first appeared to be.
Via
The Motley Fool
Is the "New" Johnson & Johnson Stock a Buy With Its Improved Profit Outlook?
October 18, 2023
Some things are different about J&J. But other things remain the same as they've been for a long time.
Via
The Motley Fool
Johnson & Johnson's Sharper Focus Is Already Paying Dividends for Investors
October 17, 2023
The healthcare behemoth reported strong earnings after separating its consumer health division.
Via
The Motley Fool
Analyst Ratings for Kenvue
October 04, 2023
Via
Benzinga
Looking At Kenvue's Recent Unusual Options Activity
September 27, 2023
Via
Benzinga
Johnson & Johnson Raises Outlook As The Health Care Bellwether Beats Views
October 17, 2023
The company beat third-quarter forecasts and raised its outlook for the year. It's now focusing on innovative drugs and medtech following its consumer health spinoff.
Via
Investor's Business Daily
New Johnson & Johnson's Q3 Earnings Beat Street View, Raises Annual Outlook
October 17, 2023
Johnson & Johnson (NYSE: JNJ) has reported Q3 FY23 adjusted earnings of $2.66 per share, up 19.3% Y/Y and beating the conse
Via
Benzinga
Topics
Earnings
Exposures
Financial
4 Dividend Stocks Yielding 4% or More to Buy Without Hesitation
October 16, 2023
These stocks offer attractive payouts that should rise in the future.
Via
The Motley Fool
Johnson & Johnson Stock: Is Now the Time to Sell?
October 14, 2023
Conservative investors buy Johnson & Johnson for the dividend, but that payout is less safe after its Kenvue spinoff
Via
InvestorPlace
7 High-Growth S&P 500 Stocks to Buy Now
October 12, 2023
Although industry stalwarts don’t typically offer robust profitability potential, these high-growth S&P 500 stocks might change your tune.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Birkenstock To Emerge After $1.6 Billion IPO For Polarizing Sandal Maker
October 10, 2023
Sometimes derided as ugly, Birkenstock "footbed" sandals continue to grow in popularity.
Via
Investor's Business Daily
Topics
Initial Public Offering
Exposures
Securities Market
2 Magnificent Dividend Kings to Buy Now
October 05, 2023
These stocks offer you income no matter what the market is doing.
Via
The Motley Fool
Most Active Equity Options For Midday - Wednesday, Oct. 4
October 04, 2023
Via
Talk Markets
Here's Why Kenvue Stock Is (Slightly) Riskier Than It Seems
October 04, 2023
It's not about to crash, but eventually, it might struggle to thrive.
Via
The Motley Fool
2 Exceptional Dividend Stocks to Buy in October and Hold Forever
October 01, 2023
Temporary challenges are creating bargain opportunities for investors with a long-term mindset.
Via
The Motley Fool
Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?
October 01, 2023
Kenvue says rewarding shareholders is an important part of its strategy.
Via
The Motley Fool
Is Kenvue Stock Too Pricey to Buy?
September 30, 2023
Its valuation depends on its brands being highly valuable indefinitely.
Via
The Motley Fool
Don’t Miss Out: 3 Dividend Stocks to Buy on EVERY. SINGLE. DIP.
September 29, 2023
Dividend stocks have proven themselves over time to outperform non-paying stocks so it's smart to buy them when they go on sale.
Via
InvestorPlace
A Bull Market Is Coming: 3 Top Dividend Stocks to Buy Now
September 29, 2023
These steadfast investments can help you earn more passive income.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.